Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Weight in Kg before and after the 16 week phase of each starch treatment with change of weight indicated over the period indicated

From: A pilot longitudinal study of the use of waxy maize heat modified starch in the treatment of adults with glycogen storage disease type I: a randomized double-blind cross-over study

ID First Pre Post Post UCCS Pre Post Post WMHMS
Starch UCCS UCCS - pre Use g/week WMHMS WMHMS - pre Use g/week
A W 57.8 58 0.2 1033 56.7 57.7 1 1047
B U 63.2 60.8 -2.4 688 65.1 72.2 7.1 1018
C U 77.6 76.4 -1.2 1480 76.5 76 -0.5 1478
D U 55 59.6 4.6 2648 59.5 55 -4.5 920
E U 73.1 72.8 -0.3 702 73.6 80.5 6.9 703
I W 50.3 52.3 2 2100 53.2 50.4 -2.8 983
  1. The amount of treatment starch taken in grammes per week is also shown in bold. See text for explanations of individual differences. The starch to which the patient was first randomized to is indicated in the second column. W = WHMHMS and U = UCCS.